Christopher Cano

Christopher Cano

Founder presso C2 Strategic LLC

53 anni
Health Technology
Consumer Services
Retail Trade

Profilo

Christopher Cano has founded C2 Strategic LLC in 2011, where he is currently the Managing Partner.
He has held former positions at Noven Pharmaceuticals, Inc., Barrier Therapeutics, Inc., Agile Therapeutics, Inc., Almirall LLC, Nucryst Pharmaceuticals Corp.
(New Jersey), Liberty Medical LLC, TFF Pharmaceuticals, Inc., and Duchesnay USA, Inc. At TFF Pharmaceuticals, Inc., he was the Vice President-Business Development from 2018 to 2020.
Mr. Cano has a graduate degree from Rider University and an undergraduate degree from Villanova University.

Posizioni attive di Christopher Cano

SocietàPosizioneInizio
C2 Strategic LLC Founder 01/01/2011
Tutte le posizioni attive di Christopher Cano

Precedenti posizioni note di Christopher Cano

SocietàPosizioneFine
TFF PHARMACEUTICALS, INC. Chief Operating Officer 18/12/2023
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
AGILE THERAPEUTICS, INC. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Christopher Cano

Formazione di Christopher Cano

Rider University Graduate Degree
Villanova University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Christopher Cano

Relazioni

14

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
AGILE THERAPEUTICS, INC.

Health Technology

TFF PHARMACEUTICALS, INC.

Health Technology

Aziende private7

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Health Technology

C2 Strategic LLC

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Christopher Cano